
Chinese General Practice ›› 2023, Vol. 26 ›› Issue (03): 356-366.DOI: 10.12114/j.issn.1007-9572.2022.0544
• Evidence-based Medicine • Previous Articles Next Articles
Received:2022-04-06
Revised:2022-08-12
Published:2023-01-20
Online:2022-09-30
Contact:
LIU Annuo
About author:
通讯作者:
刘安诺
作者简介:基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0544
| 第一作者 | 发表时间(年) | 国家/地区 | 中心数量 | 研究类型 | 样本量(例) | 诊断标准 | 影响因素 | NOS评分(分) | |
|---|---|---|---|---|---|---|---|---|---|
| 病例组 | 对照组 | ||||||||
| ABELE-HORN[ | 1998 | 德国 | 3 | 队列研究 | 48 | 49 | a | ①⑬⑭⑮⑰(21) | 9 |
| MARSHALL[ | 1999 | 美国 | 13 | 队列研究 | 224 | 641 | b | ⑧⑭⑮ | 9 |
| PI-YING[ | 2005 | 中国 | 8 | 队列研究 | 538 | 1 225 | b | ⑦⑧⑱(21) | 8 |
| TAPIA[ | 2006 | 南美 | 16 | 队列研究 | 446 | 1 379 | b | ⑭⑮⑱⑲(21) | 8 |
| HENDERSON-SMART[ | 2006 | 澳大利亚+新西兰 | 25 | 队列研究 | 2 710 | 8 743 | b | ⑨ | 8 |
| GUIMARÃES[ | 2010 | 葡萄牙 | 5 | 队列研究 | 33 | 223 | c | ⑧⑰⑳(21) | 7 |
| FARSTAD[ | 2011 | 挪威 | 全国 | 队列研究 | 324 | 53 | c | ⑬⑭⑱ | 8 |
| GORTNER[ | 2011 | 欧洲 | 10国 | 队列研究 | 677 | 3 508 | b | ③⑨⑩⑪ | 8 |
| GAGLIARDI[ | 2011 | 意大利 | 14 | 队列研究 | 196 | 1 064 | c | ⑨⑩⑯(21) | 9 |
| ROJAS[ | 2012 | 哥伦比亚 | 8 | 病例对照研究 | 64 | 148 | c | ②⑮⑱(21) | 7 |
| YEN[ | 2013 | 中国 | 21 | 队列研究 | 2 006 | 3 747 | b | ④⑦⑧⑨⑰⑱(21) | 9 |
| KLINGER[ | 2013 | 以色列 | 28 | 队列研究 | 1 663 | 10 476 | b | ③⑨⑩⑫ | 8 |
| TOLIA[ | 2014 | 美国 | 200 | 队列研究 | 3 011 | 3 199 | b | ⑦⑩⑮ | 9 |
| LAPCHAROENSAP[ | 2015 | 美国 | 116 | 队列研究 | 7 081 | 7 971 | b | ②③⑤⑨⑪ | 7 |
| ROCHA[ | 2019 | 葡萄牙 | 11 | 队列研究 | 119 | 375 | c | ④⑤⑮ | 8 |
| VALENZUELA-STUTMAN[ | 2019 | 智利 | 15 | 队列研究 | 2 580 | 13 827 | d | ⑥⑨⑫⑭⑯⑰⑱⑲(21) | 7 |
| JUNG[ | 2019 | 韩国 | 69 | 队列研究 | 1 906 | 2 756 | c | ⑨⑰ | 9 |
| EUISEOK[ | 2019 | 韩国 | 64 | 队列研究 | 816 | 618 | c | ⑨⑬⑱⑳(21) | 9 |
| 江苏省新生儿重症监护病房母乳质量改进临床研究协作组[ | 2019 | 中国 | 19 | 病例对照研究 | 191 | 577 | c | ⑮⑰(21) | 8 |
| SHIN[ | 2020 | 韩国 | KNN | 队列研究 | 764 | 1 603 | c | ①⑦⑨⑩⑰⑱ | 9 |
| NAKASHIMA[ | 2021 | 日本 | 218 | 队列研究 | 7 792 | 9 334 | c | ①⑩⑱ | 8 |
| FALEH[ | 2021 | 瑞士 | 9 | 队列研究 | 138 | 1 087 | c | ⑭⑱ | 8 |
| LI[ | 2021 | 中国 | 33 | 队列研究 | 181 | 446 | b | ⑥⑨⑫⑯ | 7 |
Table 1 Baseline characteristics of the included literature and the quality evaluation outcomes
| 第一作者 | 发表时间(年) | 国家/地区 | 中心数量 | 研究类型 | 样本量(例) | 诊断标准 | 影响因素 | NOS评分(分) | |
|---|---|---|---|---|---|---|---|---|---|
| 病例组 | 对照组 | ||||||||
| ABELE-HORN[ | 1998 | 德国 | 3 | 队列研究 | 48 | 49 | a | ①⑬⑭⑮⑰(21) | 9 |
| MARSHALL[ | 1999 | 美国 | 13 | 队列研究 | 224 | 641 | b | ⑧⑭⑮ | 9 |
| PI-YING[ | 2005 | 中国 | 8 | 队列研究 | 538 | 1 225 | b | ⑦⑧⑱(21) | 8 |
| TAPIA[ | 2006 | 南美 | 16 | 队列研究 | 446 | 1 379 | b | ⑭⑮⑱⑲(21) | 8 |
| HENDERSON-SMART[ | 2006 | 澳大利亚+新西兰 | 25 | 队列研究 | 2 710 | 8 743 | b | ⑨ | 8 |
| GUIMARÃES[ | 2010 | 葡萄牙 | 5 | 队列研究 | 33 | 223 | c | ⑧⑰⑳(21) | 7 |
| FARSTAD[ | 2011 | 挪威 | 全国 | 队列研究 | 324 | 53 | c | ⑬⑭⑱ | 8 |
| GORTNER[ | 2011 | 欧洲 | 10国 | 队列研究 | 677 | 3 508 | b | ③⑨⑩⑪ | 8 |
| GAGLIARDI[ | 2011 | 意大利 | 14 | 队列研究 | 196 | 1 064 | c | ⑨⑩⑯(21) | 9 |
| ROJAS[ | 2012 | 哥伦比亚 | 8 | 病例对照研究 | 64 | 148 | c | ②⑮⑱(21) | 7 |
| YEN[ | 2013 | 中国 | 21 | 队列研究 | 2 006 | 3 747 | b | ④⑦⑧⑨⑰⑱(21) | 9 |
| KLINGER[ | 2013 | 以色列 | 28 | 队列研究 | 1 663 | 10 476 | b | ③⑨⑩⑫ | 8 |
| TOLIA[ | 2014 | 美国 | 200 | 队列研究 | 3 011 | 3 199 | b | ⑦⑩⑮ | 9 |
| LAPCHAROENSAP[ | 2015 | 美国 | 116 | 队列研究 | 7 081 | 7 971 | b | ②③⑤⑨⑪ | 7 |
| ROCHA[ | 2019 | 葡萄牙 | 11 | 队列研究 | 119 | 375 | c | ④⑤⑮ | 8 |
| VALENZUELA-STUTMAN[ | 2019 | 智利 | 15 | 队列研究 | 2 580 | 13 827 | d | ⑥⑨⑫⑭⑯⑰⑱⑲(21) | 7 |
| JUNG[ | 2019 | 韩国 | 69 | 队列研究 | 1 906 | 2 756 | c | ⑨⑰ | 9 |
| EUISEOK[ | 2019 | 韩国 | 64 | 队列研究 | 816 | 618 | c | ⑨⑬⑱⑳(21) | 9 |
| 江苏省新生儿重症监护病房母乳质量改进临床研究协作组[ | 2019 | 中国 | 19 | 病例对照研究 | 191 | 577 | c | ⑮⑰(21) | 8 |
| SHIN[ | 2020 | 韩国 | KNN | 队列研究 | 764 | 1 603 | c | ①⑦⑨⑩⑰⑱ | 9 |
| NAKASHIMA[ | 2021 | 日本 | 218 | 队列研究 | 7 792 | 9 334 | c | ①⑩⑱ | 8 |
| FALEH[ | 2021 | 瑞士 | 9 | 队列研究 | 138 | 1 087 | c | ⑭⑱ | 8 |
| LI[ | 2021 | 中国 | 33 | 队列研究 | 181 | 446 | b | ⑥⑨⑫⑯ | 7 |
| 影响因素 | 敏感性分析前 | 敏感性分析后 | ||||
|---|---|---|---|---|---|---|
| OR值 | 95%CI | P值 | OR值 | 95%CI | P值 | |
| 母亲合并绒毛膜羊膜炎 | 1.46 | (1.18,1.80) | 0.000 6 | 1.34 | (1.11,1.62) | 0.000 2 |
| 母亲合并妊娠期高血压 | 1.26 | (1.15,1.37) | <0.000 01 | 1.23 | (1.14,1.33) | <0.000 01 |
| 母亲合并胎膜早破 | 1.18 | (1.10,1.26) | <0.000 01 | 1.18 | (1.10,1.26) | <0.000 01 |
| 母亲产前使用类固醇 | 2.38 | (0.15,37.76) | 0.54 | 2.38 | (0.15,37.76) | 0.53 |
| 母亲合并子痫前期 | 1.74 | (0.31,9.82) | 0.53 | 1.74 | (0.31,9.82) | 0.53 |
| 母亲合并妊娠期糖尿病 | 1.50 | (0.35,6.44) | 0.58 | 0.80 | (0.23,2.75) | 0.72 |
| 早产儿出生体质量 | 0.79 | (0.76,0.83) | <0.000 01 | 0.79 | (0.76,0.83) | <0.000 01 |
| 早产儿胎龄 | 0.80 | (0.73,0.87) | <0.000 01 | 0.77 | (0.71,0.85) | <0.000 01 |
| 早产儿SGA | 2.64 | (1.85,3.77) | <0.000 01 | 2.46 | (1.74,3.47) | <0.000 01 |
| 早产儿产房气管插管 | 2.50 | (1.39,4.50) | 0.002 | 2.50 | (1.39,4.51) | 0.002 |
| 早产儿5 min Apgar评分<7分 | 2.47 | (1.36,4.47) | 0.003 | 2.47 | (1.36,4.47) | 0.003 |
| 男性早产儿 | 1.49 | (1.43,1.55) | <0.000 01 | 1.49 | (1.43,1.55) | <0.000 01 |
| 早产儿机械通气 | 1.59 | (1.28,1.96) | <0.000 1 | 1.39 | (1.14,1.71) | <0.000 1 |
| 早产儿机械通气>7 d | 7.99 | (4.47,14.29) | <0.000 01 | 6.55 | (3.63,11.80) | <0.000 01 |
| 早产儿肺表面活性物质 | 3.46 | (1.96,6.11) | <0.000 1 | 3.46 | (1.96,6.11) | <0.000 1 |
| 早产儿使用类固醇 | 2.42 | (1.93,3.03) | <0.000 01 | 2.51 | (1.86,3.40) | <0.000 1 |
| 早产儿RDS | 3.40 | (2.01,5.75) | <0.000 01 | 3.23 | (1.93,5.41) | <0.000 01 |
| 早产儿PDA | 1.96 | (1.38,2.79) | 0.000 2 | 1.96 | (1.38,2.80) | 0.000 2 |
| 早产儿败血症 | 1.82 | (1.36,2.44) | <0.000 1 | 1.74 | (1.30,2.34) | <0.000 1 |
| 早产儿NEC | 1.62 | (1.18,2.22) | 0.003 | 1.62 | (1.18,2.22) | 0.003 |
| 早产儿ROP | 1.83 | (0.80,4.14) | 0.15 | 1.83 | (0.80,4.14) | 0.15 |
Table 2 Sensitivity analysis results
| 影响因素 | 敏感性分析前 | 敏感性分析后 | ||||
|---|---|---|---|---|---|---|
| OR值 | 95%CI | P值 | OR值 | 95%CI | P值 | |
| 母亲合并绒毛膜羊膜炎 | 1.46 | (1.18,1.80) | 0.000 6 | 1.34 | (1.11,1.62) | 0.000 2 |
| 母亲合并妊娠期高血压 | 1.26 | (1.15,1.37) | <0.000 01 | 1.23 | (1.14,1.33) | <0.000 01 |
| 母亲合并胎膜早破 | 1.18 | (1.10,1.26) | <0.000 01 | 1.18 | (1.10,1.26) | <0.000 01 |
| 母亲产前使用类固醇 | 2.38 | (0.15,37.76) | 0.54 | 2.38 | (0.15,37.76) | 0.53 |
| 母亲合并子痫前期 | 1.74 | (0.31,9.82) | 0.53 | 1.74 | (0.31,9.82) | 0.53 |
| 母亲合并妊娠期糖尿病 | 1.50 | (0.35,6.44) | 0.58 | 0.80 | (0.23,2.75) | 0.72 |
| 早产儿出生体质量 | 0.79 | (0.76,0.83) | <0.000 01 | 0.79 | (0.76,0.83) | <0.000 01 |
| 早产儿胎龄 | 0.80 | (0.73,0.87) | <0.000 01 | 0.77 | (0.71,0.85) | <0.000 01 |
| 早产儿SGA | 2.64 | (1.85,3.77) | <0.000 01 | 2.46 | (1.74,3.47) | <0.000 01 |
| 早产儿产房气管插管 | 2.50 | (1.39,4.50) | 0.002 | 2.50 | (1.39,4.51) | 0.002 |
| 早产儿5 min Apgar评分<7分 | 2.47 | (1.36,4.47) | 0.003 | 2.47 | (1.36,4.47) | 0.003 |
| 男性早产儿 | 1.49 | (1.43,1.55) | <0.000 01 | 1.49 | (1.43,1.55) | <0.000 01 |
| 早产儿机械通气 | 1.59 | (1.28,1.96) | <0.000 1 | 1.39 | (1.14,1.71) | <0.000 1 |
| 早产儿机械通气>7 d | 7.99 | (4.47,14.29) | <0.000 01 | 6.55 | (3.63,11.80) | <0.000 01 |
| 早产儿肺表面活性物质 | 3.46 | (1.96,6.11) | <0.000 1 | 3.46 | (1.96,6.11) | <0.000 1 |
| 早产儿使用类固醇 | 2.42 | (1.93,3.03) | <0.000 01 | 2.51 | (1.86,3.40) | <0.000 1 |
| 早产儿RDS | 3.40 | (2.01,5.75) | <0.000 01 | 3.23 | (1.93,5.41) | <0.000 01 |
| 早产儿PDA | 1.96 | (1.38,2.79) | 0.000 2 | 1.96 | (1.38,2.80) | 0.000 2 |
| 早产儿败血症 | 1.82 | (1.36,2.44) | <0.000 1 | 1.74 | (1.30,2.34) | <0.000 1 |
| 早产儿NEC | 1.62 | (1.18,2.22) | 0.003 | 1.62 | (1.18,2.22) | 0.003 |
| 早产儿ROP | 1.83 | (0.80,4.14) | 0.15 | 1.83 | (0.80,4.14) | 0.15 |
| [1] |
World health organization:preterm birth[EB/OL]. (2018-02-19) [2021-12-01].
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
江苏省新生儿重症监护病房母乳质量改进临床研究协作组. 多中心回顾性分析极低及超低出生体重儿支气管肺发育不良的临床特点及高危因素[J]. 中华儿科杂志,2019,57(1):33-39. DOI:10.3760/cma.j.issn.0578-1310.2019.01.009.
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
原晋芳,韩彤妍. 绒毛膜羊膜炎与早产儿肺部疾病研究进展[J]. 中华实用儿科临床杂志,2019,34(10):794-796. DOI:10.3760/cma.j.issn.2095-428X.2019.10.018.
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
| [51] |
|
| [1] | HE Yang, YANG Rong, SHEN Can, YI Shanye, LIU Lidi, ZHAO Qian, WAN Zhi, LIAO Xiaoyang. Progress in Research on the Trajectory of Frailty and Its Influencing Factors [J]. Chinese General Practice, 2026, 29(30): 4372-4378. |
| [2] | GUO Zhihong, CHEN Yingying, LIU Dewu. Efficacy and Safety of Antibiotic Bone Cement Combined with Vacuum Sealing Drainage for Diabetic Foot: a Meta-analysis [J]. Chinese General Practice, 2026, 29(30): 4503-4512. |
| [3] | ZHAO Congjuan, JIN Tiantian, LIANG Jie, WANG Beining, GAO Yan. Comparative Effectiveness of GLP-1 Receptor Agonists on Patients with Diabetic Kidney Disease: a Network Meta-analysis [J]. Chinese General Practice, 2026, 29(29): 4326-4336. |
| [4] | LIU Zhenyu, WANG Wendong, YAO Qing, WANG Jiangmin, CAO Wendong. Analysis of Prevalence and Influencing Factors of Cardiovascular-kidney-metabolic Syndrome among Adults in Haidian District, Beijing [J]. Chinese General Practice, 2026, 29(27): 3969-3975. |
| [5] | JIANG Yanlin, WANG Zhe, ZHAI Rui, ZHANG Mengjie, CHEN Xi, WANG Junhong. Screening Optimal Traditional Chinese Medicine Compound Formulas for ADHD Treatment: a Study Integrating Network Meta-analysis and Entropy-weighted TOPSIS Method [J]. Chinese General Practice, 2026, 29(27): 3985-3994. |
| [6] | ZHUANG Mingnan, YAN Henghao, XIAO Ningkun, YIN Mingyue, FAN Zhiwei, LIU Chaohui, ZOU Xintong, ZHOU Yuehua, BI Zhiyuan, DENG Hengzhi, WU Bitai, SONG Zhiquan, SHI Donglin. Effects of Interval and Continuous Training on Cognitive Function in Healthy Adults: a Systematic Review and Three-level Meta-analysis [J]. Chinese General Practice, 2026, 29(26): 3816-3828. |
| [7] | ZHANG Xuechao, QI Qi, WU Xinyu, HAN Quanle, LI Lei, DENG Jie, LI Cangtuo, YUE Bocheng, WU Shouling, LI Kangbo. Association between the Atherogenic Index of Plasma and New-onset Chronic Kidney Disease [J]. Chinese General Practice, 2026, 29(24): 3440-3446. |
| [8] | LI Xueni, LIU Gejing, LIU Yongming. Efficacy and Safety of Semaglutide in Patients with Heart Failure: a Meta-Analysis [J]. Chinese General Practice, 2026, 29(24): 3509-3519. |
| [9] | WANG Rui, LUO Shuoming, YANG Liang, WANG Peng, ZHAO Yang, WANG Qi, ZHOU Zhiguang. Diabetes Prevalence among Older Adults in China: a Systematic Review and Meta-analysis [J]. Chinese General Practice, 2026, 29(24): 3500-3508. |
| [10] | PEI Ruqing, ZHOU Yuqiu, ZHANG Siyu, LIU Xijun. Meta-analysis of Influencing Factors of Relapse in Chinese Patients with Schizophrenia [J]. Chinese General Practice, 2026, 29(23): 3359-3370. |
| [11] | WANG Xinliang, ZOU Nannan, CHEN Nana, WANG Xin. Analysis of Clinical Characteristics and Prognostic Risk Factors in Patients with Pulmonary Mucormycosis Complicated with Diabetes Mellitus [J]. Chinese General Practice, 2026, 29(22): 3154-3161. |
| [12] | ZHANG Ji, LI Ling, ZHOU Jie, WU Yanli, JI Wei, LIU Tao. A Prospective Cohort Study on Relationship between Lipid Accumulation Product and Incidence of Metabolic Syndrome in Adults [J]. Chinese General Practice, 2026, 29(22): 3138-3145. |
| [13] | AN Yanhong, WANG Shidong, LI Xiaoran, GUO Jiayang, WANG Zhe, SHA Peilin, MENG Yijun, LI Xiaoxuan, SHI Xue, YU Zexing, XIAO Yonghua. Study on Risk Factors and Nomogram Prediction Model for Diabetic Kidney Disease: Based on Contrast-enhanced Ultrasound Technology [J]. Chinese General Practice, 2026, 29(21): 2995-3003. |
| [14] | YANG Xiaofeng, LI Xianwen, WU Yanfeng, ZHANG Qian, CHEN Juan, ZHAO Fengjiao. Association of Serum Vascular Endothelial Cadherin Levels with the Risk of Post-stroke Cognitive Impairment in Patients with Acute Ischemic Stroke [J]. Chinese General Practice, 2026, 29(20): 2867-2873. |
| [15] | SONG Zhenzhen, CHEN Yang, WANG Jiwen, LIU Huishan, SHEN Simeng, SUN Ying, CHEN Xing. Study of Maternal Risk Factors Associated with Neonatal Asphyxia in Late Preterm and Term Infants [J]. Chinese General Practice, 2026, 29(20): 2874-2878. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||